How to Calculate
Optometry Practice Value
Three methods, one answer: what your practice is worth to a qualified buyer paying with institutional capital. EBITDA multiples, income approach, and asset-based appraisal — with a live calculator.
Valuation Science
Why the Number on the Tax Return Is Not What Your Practice Is Worth
The most common valuation mistake in optometry is applying a multiple to the wrong number. Sellers look at their tax return net income — which is deliberately minimized — and conclude their practice is worth little. Buyers look at the same number and feel they are overpaying. Both conclusions are wrong, for the same reason: the tax return does not reflect the economic reality of what the practice produces for a hypothetical market buyer.
What matters is adjusted EBITDA: earnings before interest, taxes, depreciation, and amortization, normalized to reflect the practice's true cash generation under a new owner paying themselves a market-rate salary. On a well-run single-site optometry practice, that adjustment often adds $60,000–$140,000 back to net income. That delta, multiplied by 5–7x, is the difference between a $600K and a $1.4M valuation on the same practice.
This guide explains the three formal valuation methods used in arm's-length optometry transactions, how each is constructed, where each is most reliable, and which factors move the multiple up or down in 2026 market conditions. For formal transaction preparation, see our practice valuation services. For current market multiple benchmarks, see the 2026 optometry practice multiples report.
Methodology
Three Approaches to Optometry Practice Valuation
Each method answers a different question. A defensible valuation uses all three and reconciles the results.
Income Approach (EBITDA Capitalization)
The most widely used method for optometry practices. Adjust EBITDA to reflect market-rate owner compensation, add back non-recurring items, then apply a capitalization rate (10–18%) or an income multiple (5.5–8.5x for Arizona). Answers: What is this practice worth based on what it earns?
Market Approach (Transaction Comparables)
Compares the practice to recent arm's-length sales of similar optometry practices in the same geography and revenue tier. Expressed as a revenue multiple (0.6–1.2x) or EBITDA multiple. The most persuasive method for lenders because it reflects what buyers actually paid for comparable assets.
Asset-Based Approach
Values each tangible asset at fair market value — equipment, leasehold improvements, accounts receivable, inventory — then adds separately valued goodwill. Most useful for equipment-heavy practices or as a floor value check. Produces the lowest number in most optometry valuations because it does not capture enterprise cash flow.
Core Calculation
How to Calculate Adjusted EBITDA for an Optometry Practice
Adjusted EBITDA is not a GAAP metric. It is a negotiated representation of what the practice would earn under a hypothetical, reasonably efficient operator paying a market-rate OD salary. Every add-back is a negotiation. Buyers will challenge each one. The strength of your adjusted EBITDA is determined by how well you can document every line item.
Start with net income from the most recent full calendar year tax return — not the current-year P&L, which lenders treat with more skepticism. Add back the following categories:
Standard EBITDA Add-backs: owner salary above market rate, owner benefits (health insurance, vehicle, retirement contributions run through the practice), interest on practice debt, depreciation and amortization charges, and income taxes paid at the entity level.
Non-Recurring Adjustments: one-time equipment purchases expensed rather than capitalized, legal settlements, renovation costs, and COVID-era relief funds that artificially elevated one year's income.
Market-rate OD salary for this normalization is typically $160,000–$200,000 in Arizona markets depending on subspecialty, location, and clinical volume. If the selling OD drew $120,000 in salary but the practice would need to pay a replacement OD $175,000, that $55,000 difference reduces adjusted EBITDA. It runs the other direction too: sellers who drew $350K in total compensation on a $1.1M revenue practice will find significant add-backs that increase EBITDA.
Illustrative single-site optometry practice, $1.2M revenue.
Illustrative only. Add-backs must be documented and defensible.
Interactive Tool
Practice Value Estimator
Enter your practice revenue and EBITDA margin to estimate a valuation range across three buyer tiers.
Illustrative estimate only. EBITDA margin shown pre-normalization. Actual valuation depends on payer mix, owner-dependence, lease terms, patient retention, and market conditions. Engage a formal advisory for a transaction-ready appraisal.
Value Architecture
What Moves the Multiple Up — and Down
Every optometry practice transacts somewhere in a range of 4.5x to 9.5x adjusted EBITDA. Where a specific practice lands in that range is determined by a set of factors that buyers and their advisors score explicitly before making an offer. Understanding these factors before you list your practice is the difference between a $1.8M sale and a $2.4M sale on the same earnings base.
Institutional buyers pay premium multiples for scale. Revenue above $1.5M signals a practice that will survive ownership transition.
Less reimbursement risk, higher per-patient revenue, more predictable cash flows.
Reduces owner-dependence risk. Buyers can trust revenue will survive the selling OD's departure.
Reduces location risk. Matches typical SBA term. Eliminates the lease-assignment timeline problem.
Reduces the buyer's immediate capital requirement post-close. Current-gen OCT, digital imaging.
A practice where the selling OD is the sole clinical provider and 80%+ of patients ask for them by name will see 0.5–1.5x multiple discount.
Creates financing complications, relocation risk, and renegotiation exposure. Reduces multiple 0.25–0.5x.
3+ years of declining recall rates or active patient base signals organic revenue deterioration that buyers price in aggressively.
High percentage of medical billing with Medicare reimbursement exposure creates policy risk that buyers discount at underwriting.
Revenue or EBITDA variability above 15% year-over-year creates uncertainty that both buyers and lenders will price as risk.
Goodwill Architecture
Personal Goodwill vs. Practice Goodwill: The Tax Consequence That Changes Everything
In an optometry practice sale, goodwill is divided into two legally and tax-consequentially distinct categories: personal goodwill and practice goodwill (also called enterprise goodwill). Most OD sellers have never heard this distinction. Their transaction attorney will.
Personal goodwill is the value attributable to the selling OD's individual professional reputation, patient relationships, and clinical skills — none of which transfer automatically to the buyer. Personal goodwill is owned by the individual, not the entity, and can be sold directly by the OD at capital gains rates rather than ordinary income rates in most structures.
Practice goodwill (enterprise goodwill) is the value attributable to the entity's systems, staff, location, payer contracts, and brand — assets that survive the selling OD's departure. This component is typically taxed at the entity level and may be subject to double-taxation in C-Corp structures.
For a $2M optometry practice with 70% goodwill ($1.4M), the split between personal and enterprise goodwill — and the defensibility of that split — can change the seller's after-tax proceeds by $80,000–$180,000. This is not a valuation question. It is a transaction structuring question that must be answered by a CPA with healthcare M&A experience before any offer is signed. For exit structure strategy, see our OD exit strategy guide.
An Estimate Is Not a Valuation.
Your Transaction Requires Both.
Lumina Medical Capital delivers institutional-grade optometry practice valuations built for lender underwriting, buyer negotiation, and transaction close. The estimate above tells you the range. A formal valuation tells you exactly where you stand.
Initialize Valuation Assessment →Complimentary. Confidential. Transaction-ready.
Market Data
Optometry Practice EBITDA Multiples by Revenue Tier — 2026
Estimated multiple ranges based on market research. Low = individual buyer, High = DSO/PE buyer. Results vary by practice profile.
Common Questions
Frequently Asked Questions
Optometry practices currently sell at 4.5x to 9.5x adjusted EBITDA. Individual OD buyers typically pay 4.5–7.5x. DSO and private equity buyers acquiring platform assets pay 7.0–9.5x. Scottsdale and premium markets command a 15–22% premium above statewide medians. The exact multiple depends on revenue tier, payer mix, owner-dependence, lease terms, and buyer type.
Adjusted EBITDA starts with net income from the tax return, adds back interest, taxes, depreciation, and amortization, then adjusts for non-recurring expenses, excess owner compensation (above market-rate OD salary of $160K–$200K), personal expenses run through the business, and one-time items. The adjusted figure is what buyers and lenders use — not raw net income.
Practice goodwill equals the total purchase price minus the fair market value of tangible assets. In most optometry transactions, goodwill represents 65–80% of the purchase price. It includes patient relationships, payer contracts, staff, systems, and the practice's reputation — all intangible assets that generate above-market earnings for the new owner.
Yes, significantly. Practices with over 35% cash-pay optical revenue typically command a 10–20% multiple premium. Heavy Medicare or Medicaid dependence compresses multiples due to reimbursement risk. VSP and EyeMed payer mix is broadly neutral to slightly positive given their payment stability.
The five largest value detractors are: (1) owner-dependence in single-OD practices; (2) short lease term under 5 years without renewal options; (3) declining active patient count over 3+ years; (4) aging or obsolete diagnostic equipment requiring near-term replacement; and (5) inconsistent or undocumented financials that cannot support lender underwriting at scale.